SCHEMBL10051345

SCHEMBL10051345

c1ccc(-c2ccc(-c3cc(-c4ccc(-c5ccc(-c6cc(-c7ccc(-c8ccccn8)cc7)nc(-c7ccc8ccc9cccc%10ccc7c8c9%10)n6)cc5)cc4)nc(-c4ccc5ccc6cccc7ccc4c5c67)n3)cc2)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 7/20 0.43
▸ SMN1; SMN2 Q16637 7/20 0.43
▸ KDM4E B2RXH2 6/20 0.43
▸ MAPT P10636 5/20 0.43
▸ HSD17B10 Q99714 4/20 0.43
▸ TSHR P16473 4/20 0.43
▸ LMNA P02545 4/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ PKM P14618 3/20 0.43
▸ KLF5 Q13887 2/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ MAPK1 P28482 4/20 0.41
▸ DHODH Q02127 1/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ L3MBTL1 Q9Y468 4/20 0.41
▸ NPC1 O15118 4/20 0.40
▸ HPGD P15428 3/20 0.40
▸ RAB9A P51151 4/20 0.40
▸ ALOX15 P16050 2/20 0.38
▸ ALPL P05186 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19167006 0.96 HSD17B10 (0.46) TP53SMN1; SMN2KDM4EMAPTHSD17B10
SCHEMBL10051242 0.92 DHODH (0.40) TP53SMN1; SMN2KDM4EMAPTHSD17B10
SCHEMBL19167377 0.92 HSD17B10 (0.45) TP53SMN1; SMN2KDM4EMAPTHSD17B10
SCHEMBL19168482 0.90 HPGD (0.41) TP53SMN1; SMN2KDM4EMAPTHSD17B10
SCHEMBL19166991 0.88 HSD17B10 (0.44) TP53SMN1; SMN2KDM4EMAPTHSD17B10
SCHEMBL19167646 0.88 HPGD (0.42) TP53SMN1; SMN2KDM4EMAPTHSD17B10
SCHEMBL19168095 0.88 HPGD (0.42) TP53SMN1; SMN2KDM4EMAPTHSD17B10
SCHEMBL19167359 0.88 MAPT (0.42) TP53SMN1; SMN2KDM4EMAPTHSD17B10
SCHEMBL19166280 0.88 MAPT (0.42) TP53SMN1; SMN2KDM4EMAPTHSD17B10
SCHEMBL19167002 0.88 HPGD (0.42) TP53SMN1; SMN2KDM4EMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120104941-A1 COMPOUND FOR AN ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2012-05-03 — — US disclosed
US-20120104941-A1 COMPOUND FOR AN ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2012-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120104941-A1 COMPOUND FOR AN ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME PPOX, TYR, VDAC3 TP53 2215/4885SMN1; SMN2 4736/4885KDM4E 1040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback